1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethylcarbamoyl)-2-methylcyclopropane-1-carboxylic acid
C14H16N2O5 — CID 167811816
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethylcarbamoyl)-2-methylcyclopropane-1-carboxylic acid
1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethylcarbamoyl)-2-methylcyclopropane-1-carboxylic acid (PubChem CID 167811816) has the molecular formula C14H16N2O5 and a molecular weight of 292.29 g/mol. Its IUPAC name is 1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethylcarbamoyl)-2-methylcyclopropane-1-carboxylic acid.
Molecular Properties
| Compound Name | 1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethylcarbamoyl)-2-methylcyclopropane-1-carboxylic acid |
|---|---|
| PubChem CID | 167811816 |
| Molecular Formula | C14H16N2O5 |
| Molecular Weight | 292.29 g/mol |
| Exact Mass | 292.11 |
| IUPAC Name | 1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethylcarbamoyl)-2-methylcyclopropane-1-carboxylic acid |
| SMILES | CC1CC1(C(=O)O)C(=O)NCc1ccc2c(n1)OCCO2 |
| InChI | InChI=1S/C14H16N2O5/c1-8-6-14(8,13(18)19)12(17)15-7-9-2-3-10-11(16-9)21-5-4-20-10/h2-3,8H,4-7H2,1H3,(H,15,17)(H,18,19) |
| InChIKey | VVBWJWVUEIIUAG-UHFFFAOYSA-N |
| XLogP | 0.58 |
| TPSA | 97.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 292.29 |
| LogP ≤ 5 | 0.58 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167811816 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.